Group 1 - The healthcare sector has become a hot investment target since 2025, with a remarkable increase of 91.2% from the beginning of the year to late August, making it the best-performing sector among the 12 industry indices of the Hang Seng Composite Index [1] - Home Control, a Hong Kong stock, is expanding into the healthcare field from its core IoT business, establishing connections with Singaporean medical enterprises and Indonesian consortiums [1] - The management team of Home Control includes experienced professionals from Philips, indicating a strong international board background that enhances the company's strategic positioning in the healthcare sector [1] Group 2 - Newly appointed non-executive director Ma Ying has extensive experience in digital healthcare and has established significant connections in the public welfare and education sectors, which may benefit the company's future strategic expansion in fintech and healthcare integration [1] - Another new independent non-executive director, Chen Yizhong, is the COO of OUE Limited, a Singapore-listed healthcare and real estate group, which has substantial financial resources and networks due to its ties with the Indonesian conglomerate Lippo Group [2] - OUE Limited operates over 130 clinics and medical centers across Singapore, China, Myanmar, Indonesia, and Japan, and collaborates with Chinese University of Hong Kong to establish an international medical center in Shenzhen [2] Group 3 - Home Control has launched a strategic initiative in the healthcare sector by establishing a wholly-owned subsidiary, Orbiva Limited, in Hong Kong, focusing on AIoT-enabled home healthcare platforms and ecosystems [3] - The company plans to develop smart health monitoring devices and interactive products, integrating innovative technologies such as artificial intelligence and Web3 to enhance platform capabilities and expand application scenarios [3] - The healthcare segment contributed nearly 20% to the company's growth in the first half of 2025, indicating significant potential for attracting investment as it integrates innovative technologies into a one-stop health management platform [3]

Group 1 - The company has established a wholly-owned subsidiary in Hong Kong named Orbiva Limited, with the registration completed on September 22, 2025 [1] - The decision to create Orbiva Limited is driven by the increasing global demand for healthcare and the company's achievements in the healthcare sector, leveraging its expertise in IoT and smart control technologies [1] - Orbiva Limited will serve as a new strategic core for the company, focusing on expanding its healthcare-related business, including an AIoT-enabled home healthcare platform and ecosystem [1] Group 2 - The company will maintain its existing product-based healthcare business while allowing Orbiva Limited to operate independently under the original structure [1] - The new brand under Orbiva Limited will aim to integrate hardware, software, data, and services to provide comprehensive healthcare operational services [1]

Core Insights - HOME CONTROL (01747) has established a wholly-owned subsidiary named Orbiva Limited in Hong Kong to expand its healthcare business in response to growing global healthcare demands [1][2] - Orbiva Limited will focus on developing an AIoT-enabled home healthcare platform and ecosystem, integrating hardware, software, data, and services [1] Company Developments - The formation of Orbiva Limited was completed on September 22, 2025, under Hong Kong's Companies Ordinance [1] - The company aims to leverage its existing IoT and smart control technologies along with the expertise of its new board members to drive its healthcare initiatives [1] Strategic Partnerships - Orbiva Limited is exploring collaborations with renowned academic institutions for joint laboratories and other suitable forms of cooperation in technology research and development [2] - The company is in discussions with leading hardware suppliers to define and develop products, as well as engaging with fintech institutions for innovative business models [2] - The board anticipates progress in these collaborations and will continue to seek partnership opportunities in the outlined business directions [2]

Core Viewpoint - The company has established a wholly-owned subsidiary, Orbiva Limited, in Hong Kong to expand its healthcare business, leveraging its expertise in IoT and smart control technologies [1][2] Group 1: Company Establishment - Orbiva Limited was officially registered on September 22, 2025, under Hong Kong's Companies Ordinance and other applicable laws [1] - The new subsidiary will serve as a strategic core for the company, focusing on broader healthcare-related business opportunities [1] Group 2: Business Strategy - The company aims to maintain its existing product-based healthcare operations while independently operating Orbiva Limited [1] - Orbiva Limited will focus on developing an AIoT-enabled home healthcare platform and ecosystem, integrating hardware, software, data, and services [1] Group 3: Future Development - The board is optimistic about Orbiva Limited's future, exploring collaborations with renowned academic institutions for joint laboratories [2] - The company is in discussions with leading hardware suppliers for product definition and development [2] - Initial communications are underway with fintech institutions to explore innovative business models [2]